Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1;65(1):134-147.
doi: 10.1097/GRF.0000000000000666.

COVID-19 Infection, Prevention, and Control Considerations in the Obstetric Environment

Affiliations

COVID-19 Infection, Prevention, and Control Considerations in the Obstetric Environment

Karen Acker et al. Clin Obstet Gynecol. .

Erratum in

Abstract

Pregnancy increases the risk of severe illness due to coronavirus disease 2019 (COVID-19). Thus, prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in all obstetrical health care settings requires consistent implementation of multiple evidence-based practices and consideration of local epidemiology, local regulations for COVID-19, and guidance from the Centers for Disease Control and Prevention and Professional Societies. COVID-safe practices should be implemented for patients, visitors/support persons, and health care personnel and include screening, appropriate personal protective equipment, and transmission precautions. Vaccination of all health care personnel, pregnant people, and their support persons remains the best strategy to prevent COVID-19.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Evaluations of exposures to COVID-19 in scenarios with and without aerosol-generating procedures. A, Exposures without aerosol-generating procedures. B, Exposures with aerosol-generating procedures. 1Not considered an exposure if HCW wearing a surgical mask and eye protection and infectious person not wearing a mask. COVID-19 indicates coronavirus disease 2019; HCW, health care worker; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

References

    1. Allotey J, Stalllings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. - PMC - PubMed
    1. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19—COVID-NET, 13 states, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1347–1354. - PMC - PubMed
    1. Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020;2:S1–S7. - PMC - PubMed
    1. Centers for Disease Control and Prevention (CDC). Delta variant: what we know about the science 2021.
    1. Abu-Raddad LJ, Chemaitelly H, Malek JA, et al. Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense re-exposure setting. Clin Infect Dis. 2021;73:e1830–e1840. - PMC - PubMed